Stock STRM STREAMLINE HEALTH SOLUTIONS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Streamline Health Solutions, Inc.

Equities

STRM

US86323X1063

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
0.329 USD +2.81% Intraday chart for Streamline Health Solutions, Inc. +7.87% -22.59%
Apr. 30 Transcript : Streamline Health Solutions, Inc., Q4 2024 Earnings Call, Apr 30, 2024
Apr. 29 Streamline Health Solutions, Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024 CI

Valuation

Fiscal Period: January 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 32.51 56.42 63.8 120.6 22.17 19.79 - -
Enterprise Value (EV) 1 32.51 56.42 63.8 120.6 22.17 19.79 19.79 19.79
P/E ratio -8.46 x 185 x -8.56 x -9.39 x -1.18 x -2.99 x -5.48 x -
Yield - - - - - - - -
Capitalization / Revenue 1.57 x 4.97 x 3.67 x 4.85 x 0.98 x 0.99 x 0.95 x 0.86 x
EV / Revenue 1.57 x 4.97 x 3.67 x 4.85 x 0.98 x 0.99 x 0.95 x 0.86 x
EV / EBITDA 10.4 x -29.8 x -31.3 x -32.1 x -16 x 34.1 x 4.56 x -
EV / FCF - -25.4 x -18 x -16.9 x - -6.71 x 82.8 x 9.55 x
FCF Yield - -3.93% -5.56% -5.93% - -14.9% 1.21% 10.5%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 29,559 30,497 46,570 55,852 56,849 60,163 - -
Reference price 2 1.100 1.850 1.370 2.160 0.3900 0.3290 0.3290 0.3290
Announcement Date 4/22/20 4/21/21 4/27/22 4/26/23 4/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: January 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 20.74 11.35 17.38 24.89 22.6 19.99 20.83 22.91
EBITDA 1 3.133 -1.893 -2.037 -3.757 -1.386 0.581 4.345 -
EBIT 1 -2.141 -5.946 -10.77 -10.83 -19.65 -5.993 -2.629 -0.573
Operating Margin -10.32% -52.41% -61.95% -43.52% -86.95% -29.99% -12.62% -2.5%
Earnings before Tax (EBT) 1 -2.841 -6.059 -6.808 -11.31 -18.74 -7.153 -3.789 -
Net income 1 -2.863 0.296 -6.917 -11.38 -18.7 -7.153 -3.789 -
Net margin -13.8% 2.61% -39.8% -45.72% -82.74% -35.79% -18.19% -
EPS 2 -0.1300 0.0100 -0.1600 -0.2300 -0.3300 -0.1100 -0.0600 -
Free Cash Flow 1 - -2.22 -3.545 -7.153 - -2.952 0.239 2.072
FCF margin - -19.57% -20.4% -28.74% - -14.77% 1.15% 9.04%
FCF Conversion (EBITDA) - - - - - - 5.5% -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 4/22/20 4/21/21 4/27/22 4/26/23 4/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: January 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 5.514 6.046 5.935 5.992 6.217 6.745 5.332 5.77 6.133 5.361 4.312 4.969 5.466 5.238
EBITDA 1 -0.298 -0.3 -1.693 -1.096 -1.172 -0.207 -1.337 -0.893 0.413 0.431 -0.589 0.109 0.544 0.518
EBIT 1 -3.82 -2.107 -3.177 -2.656 -3.162 -1.836 -2.996 -2.598 -12.95 -1.106 -2.195 -1.522 -1.112 -1.163
Operating Margin -69.28% -34.85% -53.53% -44.33% -50.86% -27.22% -56.19% -45.03% -211.1% -20.63% -50.9% -30.63% -20.34% -22.2%
Earnings before Tax (EBT) 1 -4.375 0.096 -2.776 -3.27 -3.129 -2.133 -2.848 -2.507 -12.03 -1.357 -2.485 -1.812 -1.402 -1.453
Net income 1 -4.31 -0.004 -2.787 -3.272 -3.138 -2.182 -2.901 -2.515 -11.91 -1.37 -2.485 -1.812 -1.402 -1.453
Net margin -78.16% -0.07% -46.96% -54.61% -50.47% -32.35% -54.41% -43.59% -194.21% -25.55% -57.63% -36.47% -25.65% -27.74%
EPS 2 -0.1000 -0.000100 -0.0600 -0.0700 -0.0700 -0.0400 -0.0500 -0.0400 -0.2100 -0.0200 -0.0400 -0.0300 -0.0200 -0.0200
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 12/8/21 4/27/22 6/8/22 9/7/22 12/14/22 4/26/23 6/12/23 9/13/23 12/13/23 4/29/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: January 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -2.22 -3.55 -7.15 - -2.95 0.24 2.07
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.05 0.04 0.04 0.01 - 1.51 1.55 1.59
Capex / Sales 0.25% 0.39% 0.24% 0.04% - 7.56% 7.43% 6.92%
Announcement Date 4/22/20 4/21/21 4/27/22 4/26/23 4/29/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Streamline Health Solutions, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.329 USD
Average target price
1.5 USD
Spread / Average Target
+355.93%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
STREAMLINE HEALTH SOLUTIONS, INC. Stock Streamline Health Solutions, Inc.
-22.59% 19.79M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.63% 83.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+0.14% 27.04B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-11.48% 16.96B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.39% 16.86B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.89% 15.76B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+1.25% 12.76B
NATERA, INC. Stock Natera, Inc.
+73.23% 13.33B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+72.58% 12.74B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+1.53% 12.32B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. STRM Stock
  4. Financials Streamline Health Solutions, Inc.